Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxycodone
Drug ID BADD_D01645
Description Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917.[A178696] It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label] The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.[L6460]
Indications and Usage Oxycodone is indicated for the treatment of moderate to severe pain.[Label] There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label]
Marketing Status approved; illicit; investigational
ATC Code N02AA05
DrugBank ID DB00497
KEGG ID D05312
MeSH ID D010098
PubChem ID 5284603
TTD Drug ID D07WPQ
NDC Product Code 71335-0981; 67651-0304; 67651-0305; 67651-0306; 24510-140; 71335-1080; 0904-6966; 24510-130; 65162-048; 67877-625; 71335-0677; 65162-050; 0904-7180; 65162-047; 72162-1812; 67877-623; 67651-0302; 65162-049; 67651-0303; 65162-051; 24510-110; 24510-115; 71335-1023; 24510-120; 72162-1811
UNII CD35PMG570
Synonyms Oxycodone | Dihydrone | Oxycone | Dihydrohydroxycodeinone | Oxycodeinon | Eucodal | Theocodin | Oxycodone Hydrochloride | Oxycontin | Pancodine | Dinarkon | Oxiconum
Chemical Information
Molecular Formula C18H21NO4
CAS Registry Number 76-42-6
SMILES CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Drowning12.01.18.003; 08.04.01.0140.000031%Not Available
Lung carcinoma cell type unspecified stage IV22.08.01.019; 16.19.02.0060.000041%Not Available
Nasal necrosis22.04.03.0200.000021%Not Available
Neglect of personal appearance19.01.02.015--Not Available
Oesophageal adenocarcinoma16.13.06.002; 07.21.06.0020.000021%Not Available
Post-traumatic stress disorder19.06.06.0020.000311%Not Available
Pupil fixed06.05.03.012; 17.02.11.0080.000031%Not Available
Reading disorder19.21.05.0030.000021%Not Available
Slow response to stimuli17.02.05.0630.000046%Not Available
Social anxiety disorder19.06.03.0100.000031%Not Available
Symptom masked08.01.03.0780.000041%Not Available
Throat cancer22.08.02.008; 16.19.02.0070.000041%Not Available
Trance19.01.02.0180.000021%Not Available
Neonatal hypotension18.04.07.008; 24.06.03.0140.000021%Not Available
Spinal cord ischaemia24.04.06.040; 17.10.01.0180.000052%Not Available
Self esteem decreased19.05.02.0040.003697%Not Available
Acute chest syndrome24.03.08.006; 22.06.03.004; 01.04.02.0040.000021%Not Available
Self esteem inflated19.05.02.0030.000249%Not Available
Biliary dilatation09.02.03.0040.000031%Not Available
Multi-organ disorder08.01.03.0740.000041%Not Available
Sopor19.02.04.002; 17.02.04.021--Not Available
Coma neonatal18.04.04.008; 17.02.09.0080.000021%Not Available
Female genital tract fistula12.02.14.010; 23.07.04.015; 21.10.05.009; 20.08.01.007; 07.11.05.004--Not Available
Foaming at mouth07.05.05.019; 17.02.05.056; 08.01.03.070--Not Available
Accidental death12.01.08.040; 08.04.01.0130.000031%Not Available
Visceral congestion24.03.02.0330.000021%Not Available
Velopharyngeal incompetence22.04.05.020; 07.05.01.0200.000041%Not Available
Heart valve incompetence02.07.02.0030.000021%Not Available
Acute lung injury22.01.03.0100.000062%Not Available
Psychological trauma19.01.02.0170.000476%Not Available
The 15th Page    First    Pre   15 16    Next   Last    Total 16 Pages